Live feed
Filing
SC 13D/A
SC 13D/A0001829126-23-001528·Organicell Regenerative Medicine, Inc.
Schedule 13D ownership disclosure
BIOTECH PRODUCT SERVICES & RES
Security class unavailable · CUSIP: 09074L105
Event date: 2022-08-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-23-001528
- Form type
- SC 13D/A
- Filer
- Organicell Regenerative Medicine, Inc.
- CIK
- CIK 1557376
- Filed
- Feb 14, 2023
- Reporting period
- Aug 16, 2022
- Description
- Schedule 13D beneficial ownership